Breast Cancer
FY22 Breakthrough Award - Funding Level 1
The list of Fiscal Year 2022 Breast Cancer Research Program Breakthrough Award - Funding Level 1 applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Dana-Farber Cancer Institute | Ming-Ru Wu |
Dana-Farber Cancer Institute | Qiwei Wang |
Health Research, Inc., Roswell Park Division | Andrei Bakin |
Icahn School of Medicine at Mount Sinai | Zhe Ying |
University of Louisville | Geoffrey Clark |
Last updated Thursday, October 13, 2022